| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland 20892 [Z. Z., A. O. V., M. R. E-B., M. J. M., L. A. L., P. H. D.]; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts 02114 [E. J. M.]; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115 [R. O.]; and Department of Internal Medicine, Catholic University Medical College, Seoul, Korea [H. M.]
Adenocarcinoma in Barrett's esophagus is the second most rapidly increasing cancer in western society. The cause and pathogenesis are unknown. Although histological studies suggest that there is successive progression from metaplasia and dysplasia, with a high risk of subsequent invasive carcinoma, at present there is no direct evidence that metaplastic and dysplastic epithelia are clonal precursors of adenocarcinoma.
We selected 12 esophagectomy specimens of Barrett's esophagus patients, which showed a spectrum of normal tissue, metaplasia, dysplasia, and invasive adenocarcinoma in each individual biopsy. We applied the microdissection technique to selectively procure microscopic tissue samples from H&E-stained slides for genetic evaluation using polymorphic markers flanking the APC gene locus.
Identical APC gene alterations were found in the dysplastic and adenocarcinoma foci of all informative cases. The same changes were observed even in some metaplastic foci adjacent to dysplasia. Furthermore, clonality analysis of X-chromosome inactivation in female cases verified the same X-chromosome inactivation pattern in carcinoma, dysplasia, and metaplasia adjacent to dysplasia. No APC gene alterations were found in the normal epithelium and metaplasia distant from dysplasia.
These data show for the first time that a tissue field of genotypic changes precedes the histopathological phenotypic changes of carcinoma in Barrett's esophagus syndrome. Our findings, in conjunction with the applied tissue microdissection technique, may help identify genotypic changes in patients with Barrett's esophagus before phenotypic changes occur. Therefore, genotyping of Barrett's metaplastic epithelium may supplement the histopathological evaluation of Barrett's esophagus.
1 To whom requests for reprints should be addressed, at Laboratory of Pathology, National Cancer Institute, Building 10, Room 2N214, Bethesda, MD 20892.
Received 1/29/96. Accepted 3/18/96.
This article has been cited by other articles:
|
|
 |
|
  Y. Xu, F. M. Selaru, J. Yin, T. T. Zou, V. Shustova, Y. Mori, F. Sato, T. C. Liu, A. Olaru, S. Wang, et al. Artificial Neural Networks and Gene Filtering Distinguish Between Global Gene Expression Profiles of Barrett's Esophagus and Esophageal Cancer Cancer Res., June 1, 2002; 62(12): 3493 - 3497. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. C. King and A. A. Sinha Gene Expression Profile Analysis by DNA Microarrays: Promise and Pitfalls JAMA, November 14, 2001; 286(18): 2280 - 2288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kurose, S. Hoshaw-Woodard, A. Adeyinka, S. Lemeshow, P. H. Watson, and C. Eng Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: clues to tumour-microenvironment interactions Hum. Mol. Genet., September 1, 2001; 10(18): 1907 - 1913. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. H. J. Riegman, K. J. Vissers, J. C. Alers, E. Geelen, W. C. J. Hop, H. W. Tilanus, and H. van Dekken Genomic Alterations in Malignant Transformation of Barrett's Esophagus Cancer Res., April 1, 2001; 61(7): 3164 - 3170. [Abstract] [Full Text]
|
|
|
|
|
|
C. A. Eads, R. V. Lord, K. Wickramasinghe, T. I. Long, S. K. Kurumboor, L. Bernstein, J. H. Peters, S. R. DeMeester, T. R. DeMeester, K. A. Skinner, et al. Epigenetic Patterns in the Progression of Esophageal Adenocarcinoma Cancer Res., April 1, 2001; 61(8): 3410 - 3418. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Kawakami, J. Brabender, R. V. Lord, S. Groshen, B. D. Greenwald, M. J. Krasna, J. Yin, A. S. Fleisher, J. M. Abraham, D. G. Beer, et al. Hypermethylated APC DNA in Plasma and Prognosis of Patients With Esophageal Adenocarcinoma J Natl Cancer Inst, November 15, 2000; 92(22): 1805 - 1811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Eads, R. V. Lord, S. K. Kurumboor, K. Wickramasinghe, M. L. Skinner, T. I. Long, J. H. Peters, T. R. DeMeester, K. D. Danenberg, P. V. Danenberg, et al. Fields of Aberrant CpG Island Hypermethylation in Barrett's Esophagus and Associated Adenocarcinoma Cancer Res., September 1, 2000; 60(18): 5021 - 5026. [Abstract] [Full Text]
|
|
|
|
 |
|
 F. Fend and M. Raffeld Laser capture microdissection in pathology J. Clin. Pathol., September 1, 2000; 53(9): 666 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. E. Steele, C. A. Holmes, E. T. Hawk, L. Kopelovich, R. A. Lubet, J. A. Crowell, C. C. Sigman, and G. J. Kelloff Lipoxygenase Inhibitors as Potential Cancer Chemopreventives Cancer Epidemiol. Biomarkers Prev., May 1, 1999; 8(5): 467 - 483. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. A. Jankowski, N. A. Wright, S. J. Meltzer, G. Triadafilopoulos, K. Geboes, A. G. Casson, D. Kerr, and L. S. Young Molecular Evolution of the Metaplasia-Dysplasia-Adenocarcinoma Sequence in the Esophagus Am. J. Pathol., April 1, 1999; 154(4): 965 - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Fend, M. R. Emmert-Buck, R. Chuaqui, K. Cole, J. Lee, L. A. Liotta, and M. Raffeld Immuno-LCM: Laser Capture Microdissection of Immunostained Frozen Sections for mRNA Analysis Am. J. Pathol., January 1, 1999; 154(1): 61 - 66. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-T. Wu, T. Watanabe, R. Heitmiller, M. Zahurak, A. A. Forastiere, and S. R. Hamilton Genetic Alterations in Barrett Esophagus and Adenocarcinomas of the Esophagus and Esophagogastric Junction Region Am. J. Pathol., July 1, 1998; 153(1): 287 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Rabkin, S. Janz, A. Lash, A. E. Coleman, E. Musaba, L. Liotta, R. J. Biggar, and Z. Zhuang Monoclonal Origin of Multicentric Kaposi's Sarcoma Lesions N. Engl. J. Med., April 3, 1997; 336(14): 988 - 993. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Deng, Y. Lu, G. Zlotnikov, A. D. Thor, and H. S. Smith Loss of Heterozygosity in Normal Tissue Adjacent to Breast Carcinomas Science, December 20, 1996; 274(5295): 2057 - 2059. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
